Cure’nCaps Solutions is a contract service-based Business Unit of Gliocure SA specialized in the development of injectable nanomedicines for human and animal health using innovative controlled drug delivery platforms.
Examples of benefits provided by technology platforms and know-how:
- Solubilization, transport and targeting of poorly water-soluble drugs
- Improved pharmacokinetics and duration of action of therapeutic proteins and peptides through sustained delivery
- Use of non-toxic GRAS/FDA approved excipients
- Straightforward manufacturing processes avoiding the use of toxic organic solvents
- Gene transfer using non-viral vectors
- Lipid-nanoparticles for mRNA delivery
Cure'nCaps provides specific solutions to your needs
Non exhaustive list of therapeutic domains that can benefit from our technologies and know-how:
- Diabetes
- Cancer
- Hemophilia
- Anemia
- Eye diseases (AMD, diabetic retinopathy)
- Infectious diseases
- Growth hormone deficiency
- Hepatitis
- Wound healing
Controlled delivery of a large number of pharmaceutical ingredients:
- Small chemical entities
- Peptides
- Proteins (such as antibodies and their fragments)
- Nucleic acids (DNA, mRNA)
- Contrast agents